Pfizer Eyes EU Pegfilgrastim Roll-Out By 1 April As US Launch Is Confirmed

No Update On Infringement Proceedings Over Protein Purification Patent

Red_Rocket
Pfizer's pegfilgrastim product, Nyvepria, is the fourth biosimilar Neulasta product available in the US • Source: Shutterstock

More from Biosimilars

More from Products